In a very elegant publication, Mi and Lou showed that vandetanib reversed p-glycoprotein-mediated multidrug resistance to Adriamycin, docetaxel, and vinorelbine in two p-glycoprotein-overexpressed breast cancer cell lines derived from MCF-7/Adriamycin and KBV200 [115]. Here, ABCB1 is linked to breast cancer.